ZUO LI YAO YE(SZ:300181)2022-12-08 08:02Group 1: Acquisition and Shareholding Structure - The company has completed the acquisition of 51% of Qinghai Zhu Feng Winter Worm Summer Grass Pharmaceutical Co., Ltd. and considers the current shareholding structure beneficial for both parties [1][2] - Future acquisition of the remaining shares will depend on conditions and long-term considerations [2] Group 2: Patent and Legal Risks - A patent related to the fermentation production method of winter worm summer grass is set to expire in April 2017, and no infringement lawsuits have been received [2][3] - The company has assessed that its production does not infringe on existing patents, and agreements are in place to ensure raw material supply [3] Group 3: Future Development Goals - The company aims to focus on medicinal fungi, developing products like Wuling Capsules and integrating the advantages of acquired products [4][5] - Four key areas for future growth have been identified: marketing, project acquisition, research and development, and management improvement [5] Group 4: Market Development for New Products - The market potential for Linglianhua Granules and Lingze Tablets is significant, but they are in the cultivation phase due to low recognition among doctors and patients [6] - The company plans to expand Wuling Capsule sales while nurturing the new products [6] Group 5: Integration and Management - Integration with Qinghai Zhu Feng Winter Worm Summer Grass Pharmaceutical Co., Ltd. is actively progressing, with new board members and executives involved [8] - Consolidation efforts are ongoing to ensure smooth operations post-acquisition [8]